Publications

BibTex format

@article{Cho:2022,
author = {Cho, BC and Lin, J and Camidge, DR and Velcheti, V and Solomon, B and Lu, S and Lee, KH and Kim, SW and Kao, S and Diadziuskzko, R and Beg, M and Nagasaka, M and Felip, E and Besse, B and Springfeld, C and Popat, S and Wolf, J and Trone, D and Stopatschinskaja, S and Drilon, A},
journal = {EUROPEAN JOURNAL OF CANCER},
pages = {S1--S2},
title = {Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+advanced non-small cell lung cancer (NSCLC)},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000876973400003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
volume = {174},
year = {2022}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Cho,BC
AU  - Lin,J
AU  - Camidge,DR
AU  - Velcheti,V
AU  - Solomon,B
AU  - Lu,S
AU  - Lee,KH
AU  - Kim,SW
AU  - Kao,S
AU  - Diadziuskzko,R
AU  - Beg,M
AU  - Nagasaka,M
AU  - Felip,E
AU  - Besse,B
AU  - Springfeld,C
AU  - Popat,S
AU  - Wolf,J
AU  - Trone,D
AU  - Stopatschinskaja,S
AU  - Drilon,A
EP  - 2
PY  - 2022///
SN  - 0959-8049
SP  - 1
TI  - Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+advanced non-small cell lung cancer (NSCLC)
T2  - EUROPEAN JOURNAL OF CANCER
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000876973400003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 174
ER  -

Download

DrSanjayPopat

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)